Diabetes Research Center

Diabetes Research Center (DRC) is a specialized clinical research organization and dedicated site focused on the advancement of metabolic and endocrine medicine. Headquartered in Tustin, California, the center conducts Phase I through IV clinical trials in collaboration with global pharmaceutical leaders and emerging biotechnology firms. The organization specializes in complex study designs, including pharmacokinetic and pharmacodynamic assessments for novel insulins, GLP-1 receptor agonists, and weight-loss therapeutics. With a robust infrastructure for patient recruitment and regulatory management, DRC serves as a pivotal link in the clinical development pipeline for treatments targeting Type 1 and Type 2 diabetes, obesity, and non-alcoholic steatohepatitis (NASH). The center is recognized for its expertise in conducting glucose clamp studies and managing large-scale recruitment for metabolic clinical trials.